Brainstorm Cell Therapeutics Inc.
OTC: BCLI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chaim Lebovits
- Employees
- 27
- Headquarters
- New York City, United States
- IPO year
- 2003
- Market cap
- $10.3M
- Website
- https://www.brainstorm-cell.com
Loading BCLI…
Loading profile data…Frequently asked questions about BCLI
What does Brainstorm Cell Therapeutics Inc. (BCLI) do?
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platfor...
Where does BCLI trade?
Brainstorm Cell Therapeutics Inc. (BCLI) trades on the Other OTC.
What sector is BCLI in?
Brainstorm Cell Therapeutics Inc. (BCLI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Brainstorm Cell Therapeutics Inc.?
Chaim Lebovits is the chief executive officer of Brainstorm Cell Therapeutics Inc. (BCLI).
Where is Brainstorm Cell Therapeutics Inc. headquartered?
Brainstorm Cell Therapeutics Inc. is headquartered in United States.
Does BCLI pay a dividend?
Brainstorm Cell Therapeutics Inc. (BCLI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BCLI go public?
Brainstorm Cell Therapeutics Inc. (BCLI) completed its initial public offering in 2003.